US Patent 8846622 Targeted delivery of botulinum toxin to the sphenopalatine ganglion

Patent 8846622 was granted and assigned to Allergan, Inc. on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Allergan, Inc.

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88466220

Patent Inventor Names

Andrew M. Blumenfeld0

Date of Patent

September 30, 2014

Patent Application Number

139675000

Date Filed

August 15, 2013

Patent Citations Received

‌

US Patent 11712464 Intervention device

Patent Primary Examiner

‌

Chih-Min Kam

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846622 Targeted delivery of botulinum toxin to the sphenopalatine ganglion

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API